Stockscreener 앱 받기
13.72
1.22%
-0.17
시간 외 거래:
13.78
0.06
+0.44%
전일 마감가:
$13.89
열려 있는:
$13.78
하루 거래량:
61,710
Relative Volume:
0.87
시가총액:
$194.49M
수익:
$166.88M
순이익/손실:
$-74.18M
주가수익비율:
-2.7061
EPS:
-5.07
순현금흐름:
$1.14M
1주 성능:
+4.41%
1개월 성능:
-13.76%
6개월 성능:
-45.45%
1년 성능:
-45.79%
1일 변동 폭
$13.48
$13.97
1주일 범위
$12.83
$14.32
52주 변동 폭
$12.83
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
명칭
Anika Therapeutics Inc
전화
(781) 457-9000
주소
32 WIGGINS AVENUE, BEDFORD, MA
ANIK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
13.72 | 194.49M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
149.22 | 66.56B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.54 | 45.76B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.67B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.60 | 15.58B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.82 | 12.79B | 2.76B | 1.11B | 898.10M | 22.77 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-01 | 재확인 | Barrington Research | Outperform |
| 2023-08-14 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | 재개 | Stephens | Equal-Weight |
| 2022-03-09 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | 개시 | Stephens | Overweight |
| 2021-07-16 | 개시 | UBS | Neutral |
| 2020-12-16 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-01-10 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | 개시 | BWS Financial | Sell |
| 2019-09-24 | 재확인 | Barrington Research | Outperform |
| 2019-09-23 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | 업그레이드 | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | 다운그레이드 | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2018-07-27 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | 재확인 | Barrington Research | Outperform |
| 2016-05-09 | 업그레이드 | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | 재확인 | Barrington Research | Outperform |
모두보기
Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Purchased by Wellington Management Group LLP - Defense World
Viscosupplementation Market Is Booming Worldwide 2025-2032 | - openPR.com
Arrowstreet Capital Limited Partnership Has $979,000 Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by American Century Companies Inc. - Defense World
Anika Therapeutics announces COO departure, streamlines management By Investing.com - Investing.com Canada
Anika Therapeutics announces COO departure, streamlines management - Investing.com
Anika Therapeutics Announces COO Departure and Role Elimination - TipRanks
Viscosupplementation Market Outlook: Growth Drivers - openPR.com
Anika Therapeutics stock hits 52-week low at $13.7 - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $13.7 By Investing.com - Investing.com South Africa
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Anika Grants 3,800 Share Options to New Hire: Key Details Revealed - Stock Titan
Anika Therapeutics, Inc. (NASDAQ:ANIK) Position Trimmed by HighTower Advisors LLC - Defense World
Are Options Traders Betting On A Big Move In Anika Therapeutics (ANIK) Stock? - Barchart.com
Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika - openPR.com
Europe Viscosupplementation Market Projected To Witness - openPR.com
Anika Therapeutics stock hits 52-week low at $14.9 By Investing.com - Investing.com South Africa
Anika Therapeutics stock hits 52-week low at $14.9 - Investing.com India
How the (ANIK) price action is used to our Advantage - news.stocktradersdaily.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Reduced by Charles Schwab Investment Management Inc. - Defense World
Hammertoe Solution Market Size, Trends 2031 By Key Players- - openPR.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Bank of New York Mellon Corp - Defense World
Europe Viscosupplementation Market Set to Witness Significant - openPR.com
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions - TipRanks
Anika Therapeutics, Inc. SEC 10-K Report - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika Therapeutics Inc., Seikagaku Corporation - openPR.com
Q1 Earnings Forecast for ANIK Issued By Barrington Research - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
Anika Therapeutics (NASDAQ:ANIK) Stock Rating Upgraded by StockNews.com - Defense World
Barrington Research Lowers Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00 - Defense World
Anika Therapeutics (NASDAQ:ANIK investor three-year losses grow to 45% as the stock sheds US$26m this past week - Simply Wall St
Anika Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo
Anika Therapeutics stock hits 52-week low at $15.34 By Investing.com - Investing.com Australia
Anika Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks
Anika Therapeutics stock hits 52-week low at $15.34 - Investing.com
Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips - Investing.com Australia
Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Anika Therapeutics Reports Steady Growth and Strategic Focus - TipRanks
Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Anika Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Anika Therapeutics Inc (ANIK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.07%
1.45%
자본화:
|
볼륨(24시간):